Contract packaging - a strategic move
The contract packaging biz is moving from an ad-hoc to a more strategically determined, long-term approach, as pharma companies begin to relax in the arms of service providers.
The contract packaging biz is moving from an ad-hoc to a more strategically determined, long-term approach, as pharma companies begin to relax in the arms of service providers.
The US Food and Drug Administration (FDA) has announced the launch of a new guidance to help drug makers evaluate lab test results that fall outside the specification limits.
The global contract manufacturing market is expected to exceed $26bn (€20bn) by 2011, according to new market research.